Press release
-
Press Release
The Paley Center for Media Announces Its Esteemed Honorees for The 2026 Paley Honors Spring Gala: Global Media Icon & Visionary Leader Arnaud de Puyfontaine, Innovative Executive & Creator Economy Trailblazer Robert Kyncl, and the 50th Anniversary of the Groundbreaking Television Series Charlie’s Angels with Stars Kate Jackson, Jaclyn Smith, and Cheryl Ladd
The Illustrious Event Benefits Paley’s Acclaimed Educational Programs and Preservation Initiatives within The Paley Archive, the World’s Largest Publicly Accessible…
Read More » -
Press Release
World Series of Poker, the #1 Free-to-Play Poker Game, Launches New Blackjack Game Mode
As one of the world’s most popular games, the introduction of Blackjack strengthens WSOP’s ability to deliver a diverse and…
Read More » -
Press Release
Provident Healthcare Partners Advises A Caring Experience Nursing Services, Inc. on its Acquisition by HouseWorks Holdings, LLC, a Portfolio Company of InTandem Capital Partners
BOSTON, March 11, 2026 /PRNewswire/ — Provident Healthcare Partners (“Provident”), a leading healthcare investment banking firm, announced it has advised…
Read More » -
Press Release
Vision Marine Technologies Positions for Scalable Electric Adoption Through Dominant Pontoon Segment; Introduces SPECTR 26 Flagship Platform
Corporate Updates and Strategy MONTREAL, March 11, 2026 /PRNewswire/ — Vision Marine Technologies Inc. (NASDAQ: VMAR) (“Vision Marine” or the…
Read More » -
Press Release
Data Center Market to Reach US$ 801.5 Billion by 2033 Expands Amid Digital Transformation and AI Infrastructure Demand – Persistence Market Research
LONDON, March 11, 2026 /PRNewswire/ — The global data center market is expanding rapidly, expected to be valued at around US$347.3…
Read More » -
Press Release
InventHelp Inventors Develop N-Type P D D Semi Conductor (OCM-1748)
PITTSBURGH, March 11, 2026 /PRNewswire/ — “We thought there should be a way to fabricate N-type phosphorus-doped diamond semiconductors for high…
Read More » -
Press Release
REGENXBIO REPORTS NEW POSITIVE INTERIM DATA FROM PHASE I/II AFFINITY DUCHENNE® TRIAL OF RGX-202
Investigational RGX-202 continues to demonstrate evidence of positively changing disease trajectory for Duchenne Pivotal dose participants exceeded external controls across…
Read More »
